Polyclonal Antibody to Tafazzin (TAZ)

CMD3A; EFE2; EFE; BTHS; XAP-2; G4.5; Barth syndrome; Endocardial Fibroelastosis 2; Cardiomyopathy,Dilated 3A(X-Linked)

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against TAZ. It has been selected for its ability to recognize TAZ in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPE564Ra01 Recombinant Tafazzin (TAZ) Positive Control; Immunogen; SDS-PAGE; WB.
PAE564Ra01 Polyclonal Antibody to Tafazzin (TAZ) WB; IHC; ICC; IP.